| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $46.0M | +4174.5% |
| R&D Expense | $97.6M | +49.4% |
| SG&A Expense | $29.2M | +76.1% |
| Operating Income | -$68.3M | +15.5% |
| Pre-tax Income | -$48.9M | +32.4% |
| Income Tax | $12K | +102.4% |
| Net Income | -$48.9M | +31.9% |
| EPS (Basic) | -$1.10 | +84.8% |
| EPS (Diluted) | -$1.10 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $120.7M | -49.3% |
| Short-term Investments | $270.4M | +139.8% |
| Accounts Receivable | $10.4M | +5956.1% |
| Current Assets | $411.0M | +15.2% |
| Total Assets | $596.2M | +30.6% |
| Current Liabilities | $86.9M | +576.6% |
| Total Liabilities | $214.3M | +486.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $110.2M | +263.3% |
| Capital Expenditures | $518K | -75.4% |
| Investing Cash Flow | -$229.4M | -42.8% |
| Financing Cash Flow | $1.7M | -99.6% |
| Free Cash Flow | $109.7M | +257.6% |
| +84.8% |
| Stockholders' Equity |
| $381.9M |
| -9.1% |